If your semaglutide dose is too high, you will likely experience exaggerated gastrointestinal side effects (severe nausea, vomiting, diarrhea, abdominal pain), fainting, headaches, or signs of low blood sugar
Thus, recombinant long-acting GLP-1 receptor agonists (RAs) have been developed for the treatment of type 2 diabetes mellitus (T2DM) 24,25 , and were also recently approved to treat obesity 26,27
What we need to do now in research is understand which treatments, for which patients, at which stage of their disease. This article is exclusive to STAT+ subscribers Unlock this article plus in-depth analysis, newsletters, premium events, and news alerts
Cell 92, 773784
A byproduct of any caloric deficit